🔗 Visit the ClinicalTrials.gov page for NCT01614301
Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Tumor stroma as targets for cancer therapy. | Pharmacol Ther | 2012 | 1.06 |
2 | Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoring. | Front Oncol | 2013 | 0.89 |
3 | Chemotherapy and chemoprevention by thiazolidinediones. | Biomed Res Int | 2015 | 0.85 |
4 | Biomodulatory metronomic therapy in stage IV melanoma is well-tolerated and may induce prolonged progression-free survival, a phase I trial. | J Eur Acad Dermatol Venereol | 2015 | 0.76 |